Back

Hyponatremia is associated with worse clinical markers of congestion, anemia, renal impairment, myocardial damage, neurohormonal and inflammatory activations

27 May 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Acute Heart Failure – Epidemiology, Prognosis, Outcome Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2018

About the speaker

Photo
Professor Yuksel Cavusoglu

Eskisehir Osmangazi University, Eskisehir (Turkiye)

17 More presentations in this session

Presentation thumbnail
Doctor J. Stewart (Margate, GB)
Abstract
Presentation thumbnail
Doctor T. Tarvasmaki (Helsinki, FI)
Abstract
Presentation thumbnail
Doctor A. Pratesi (Pistoia, IT)
Abstract
Presentation thumbnail
Doctor H. Kondo (Tenri, JP)
Abstract
Presentation thumbnail
Mr H. van Voorst (Alkmaar, NL)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Acute Heart Failure – Epidemiology, Prognosis, Outcome

The Event

Event poster

Heart Failure 2018

27 May 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Prevalence, patient characteristics and outcome of hyponatremia in acute heart failure
27 August 2022
thumbnail
Congress Presentation
New applications of traditional inflammation markers in heart failure prognosis
12 May 2024
thumbnail
Congress Session
Is decongestion the goal during acute heart failure treatment?
17 May 2025
thumbnail
Congress Presentation
Correlation between congestion biomarkers and total body water in acute heart failure.
22 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources